, Tracking Stock Market Picks
Enter Symbol:

up 23.04 %

HEARTWARE (HTWR) rated Overweight with price target $100 by Barclays

Posted on: Friday,  May 1, 2015  1:25 PM ET by Barclays

Barclays rated Overweight HEARTWARE (NASDAQ: HTWR) on 05/01/2015. Previously Barclays rated Overweight HEARTWARE (NASDAQ: HTWR) on 04/23/2012., when the
stock price was $70.20. Since then, HEARTWARE has gained 23.05% as of 01/28/2016's recent price of $86.38.
If you would have followed the previous Barclays's recommendation on HTWR, you would have gained 23.04% of your investment in 1375 days.

HeartWare International, Inc. (HeartWare), formerly HeartWare Limited, along with its subsidiaries, is a medical device company focused on developing small implantable pumps for the treatment of advanced heart failure. The Company?s product, the HeartWare Ventricular Assist System (the HeartWare System), includes a left ventricular assist device (LVAD), related accessories and surgical tools and is designed to provide circulatory support for patients with advanced heart failure. The core of the HeartWare System is a continuous flow blood pump, ventricular assist device (the HVAD Pump), a full-output device capable of pumping up to 10 liters of blood per minute. In January 2009, the HeartWare System received Conformite Europeene (CE) Marking, which allows for commercial sales in Europe and is the subject of an ongoing United States bridge-to-transplant clinical trial under an investigational device exemption (IDE) granted by the Food and Drug Administration of United States (FDA).

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/1/2015 1:25 PM Buy
74.88 100.00
as of 8/27/2015
1 Week down  -0.68 %
1 Month up  10.97 %
3 Months up  15.94 %
1 YTD down  -8.00 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2014 2:25 PM Buy
101.32 110.00
4/30/2013 1:25 PM Buy
95.66 100.00
4/23/2012 1:25 PM Buy
70.20 80.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy